« Back to Record
Citation APA

Loi, S., Savas, P., Lönnstedt, I. I., Fumagalli, D., Caramia, F., Li, J., Salgado, R., Rowan, A., Andre, F., Denkert, C., Neven, P., Loibl, S., Sotiriou, C., Swanton, C., & Speed, T. P. (2014). Evaluation and clinical impact of intra-tumor heterogeneity (ITH) in primary HER2-overexpressing breast cancers (HER2+BC) treated with adjuvant trastuzumab and chemotherapy (CT). Poster session presented at San Antonio Breast Cancer Symposium – SABCS (December 11, 2014: San Antonio, Tx, USA).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/244775

Loi, S., Savas, P., Lönnstedt, I. I., Fumagalli, D., Caramia, F., Li, J., Salgado, R., Rowan, A., Andre, F., Denkert, C., Neven, P., Loibl, S., Sotiriou, C., Swanton, C., & Speed, T. P. (2014). Evaluation and clinical impact of intra-tumor heterogeneity (ITH) in primary HER2-overexpressing breast cancers (HER2+BC) treated with adjuvant trastuzumab and chemotherapy (CT). Poster session presented at San Antonio Breast Cancer Symposium – SABCS (December 11, 2014: San Antonio, Tx, USA).